Interestingly, (Boston Scientific) only raised its bid by $1, signaling that price is but one factor in the negotiation - but includes timeliness of closure.

At this stage in the negotiation process, we believe decisions are being made not only on dollars and cents, but also ego, strategy and a broader view of the competitive landscape.

They're certainly making it harder for J&J to come back. Strategically we believe Boston Scientific with Guidant is a better match.

We doubt this show is over, and in the end we expect that Boston Scientific will increase its bid.

There's a phrase: to strike while the iron is hot. The iron is hot.

In our opinion this news is not new and should not slow down the merger with Guidant.